Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial
This study is a single-center randomized controlled trial. Subjects with inoperable CTEPH are randomized into either a BPA combined with riociguat or riociguat monotherapy group (2:1) and observed for 12 months after initiation of treatment. The primary endpoint is the change in pulmonary vascular resistance from baseline to 12 months after initiation of treatment. The secondary endpoints include 6-min walk distance (6MWD), WHO-FC, NT-proBNP, SF-36, and other hemodynamic parameters. Safety endp oints are analyzed too.DiscussionThis study aims to compare the efficacy and safety of BPA combined with riociguat and riocig...
Source: Trials - December 27, 2021 Category: Research Source Type: clinical trials
SIroliMus coated angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION (IMPRESSION): study protocol for a randomized controlled trial
This study will evaluate the clinical efficacy and safety of SCB compared to PBA in the treatment of AVF stenosis in hemodialysis patients.Trial registrationClinicalTrials.govNCT04409912. Registered on 1 June 2020 (Source: Trials)
Source: Trials - December 20, 2021 Category: Research Source Type: clinical trials
Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty
Condition: Chronic Total Occlusion Interventions: Device: Paclitaxel-coated Balloon dilation angioplasty; Device: Non-coated Balloon dilation angioplasty Sponsor: Ignacio J. Amat Santos Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2021 Category: Research Source Type: clinical trials
